NSAM
North Star Asset Management Portfolio holdings
AUM
$2.36B
1-Year Return
14.42%
This Quarter Return
+9.54%
1 Year Return
+14.42%
3 Year Return
+63.82%
5 Year Return
+104.72%
10 Year Return
+249.93%
AUM
$1.39B
AUM Growth
+$117M
(+9.1%)
Cap. Flow
+$2.92M
Cap. Flow
% of AUM
0.21%
Top 10 Holdings %
Top 10 Hldgs %
22.99%
Holding
299
New
9
Increased
66
Reduced
139
Closed
5
Top Buys
| 1 |
Boeing
BA
|
$3.99M |
| 2 |
Mastercard
MA
|
$2.68M |
| 3 |
PTC
PTC
|
$2.31M |
| 4 |
Danaher
DHR
|
$1.55M |
| 5 |
Synopsys
SNPS
|
$1.24M |
Top Sells
| 1 |
CBLK
Carbon Black, Inc. Common Stock
CBLK
|
$3.81M |
| 2 |
Oracle
ORCL
|
$2.42M |
| 3 |
BorgWarner
BWA
|
$1.26M |
| 4 |
Alibaba
BABA
|
$941K |
| 5 |
Global Payments
GPN
|
$817K |
Sector Composition
| 1 | Technology | 23.85% |
| 2 | Financials | 12.56% |
| 3 | Healthcare | 11.77% |
| 4 | Industrials | 10.09% |
| 5 | Consumer Discretionary | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Sysco
SYY
$39.4B
| $1.26M | 0.09% |
14,692
| – | – |
|
127
Automatic Data Processing
ADP
$120B
| $1.23M | 0.09% |
7,206
| – | – |
|
128
ASML
ASML
$307B
| $1.19M | 0.09% |
+4,015
| New | +$1.19M |
|
129
Marriott International Class A Common Stock
MAR
$71.9B
| $1.18M | 0.08% |
7,782
| – | – |
|
|
WBA
130
DELISTED
Walgreens Boots Alliance
WBA
| $1.17M | 0.08% |
19,852
-492
| -2% | -$29K |
|
131
Wells Fargo
WFC
$253B
| $1.16M | 0.08% |
21,608
-2,575
| -11% | -$138K |
|
132
Coca-Cola
KO
$292B
| $1.15M | 0.08% |
20,690
+15
| +0.1% | +$830 |
|
133
Qorvo
QRVO
$8.61B
| $1.13M | 0.08% |
9,701
| – | – |
|
134
Novo Nordisk
NVO
$245B
| $1.09M | 0.08% |
37,600
| – | – |
|
135
IBM
IBM
$232B
| $1.05M | 0.08% |
8,196
-26
| -0.3% | -$3.33K |
|
136
SPDR S&P Bank ETF
KBE
$1.62B
| $1.01M | 0.07% |
21,337
-275
| -1% | -$13K |
|
137
Merck
MRK
$212B
| $974K | 0.07% |
11,223
-802
| -7% | -$69.6K |
|
|
138
BorgWarner
BWA
$9.53B
| $960K | 0.07% |
25,151
-32,883
| -57% | -$1.26M |
|
139
Weyerhaeuser
WY
$18.9B
| $948K | 0.07% |
31,375
+545
| +2% | +$16.5K |
|
140
Bristol-Myers Squibb
BMY
$96B
| $942K | 0.07% |
14,682
+2,992
| +26% | +$192K |
|
141
Royce Value Trust
RVT
$1.96B
| $933K | 0.07% |
63,178
-6,659
| -10% | -$98.3K |
|
142
Ionis Pharmaceuticals
IONS
$9.76B
| $918K | 0.07% |
15,200
| – | – |
|
143
Avanos Medical
AVNS
$590M
| $914K | 0.07% |
27,131
-664
| -2% | -$22.4K |
|
144
IQVIA
IQV
$31.9B
| $913K | 0.07% |
5,910
| – | – |
|
145
Jabil
JBL
$22.5B
| $896K | 0.06% |
21,680
-250
| -1% | -$10.3K |
|
146
Bank of Montreal
BMO
$90.3B
| $893K | 0.06% |
11,523
-225
| -2% | -$17.4K |
|
147
Emerson Electric
EMR
$74.6B
| $878K | 0.06% |
11,517
-251
| -2% | -$19.1K |
|
148
Berkshire Hathaway Class B
BRK.B
$1.08T
| $870K | 0.06% |
3,844
+24
| +0.6% | +$5.43K |
|
149
Henry Schein
HSIC
$8.42B
| $869K | 0.06% |
13,024
| – | – |
|
150
Vertex Pharmaceuticals
VRTX
$102B
| $865K | 0.06% |
3,950
| – | – |
|